Consultancy Services
SRM College of Pharmacy has a collaboration research partnerships with numerous Pharma companies and Research Institutes for conducting various Pre Clinical and Clinical studies. The College also offers consultancy services among various areas of Research including pharmaceutics, Pharmacology, Pharmaceutical Chemistry, and Pharmaceutical Analysis.
The equipment’s and infrastructure offered for the consultancy services along with the tariff can be enquired with the following mail ID:
Dr. V. Chitra,
Dean,
SRM College of Pharmacy, SRMIST, Kattankulathur-603203
dean.pharmacy.ktr@srmist.edu.in
Sponsored And Consultancy Projects
| Sl.No. | Title | Amount | Duration | Agency | Status |
| 1 | Efficacy of Hemocare Syrup and Hemocare XT Tablets in Iron Deficiency Anemia among Women of Reproductive Age: A Randomized, Open Label Trial | Rs. 3,20,000 | July 2018-Jul 19 | MMC Pharmaceuticals. Ltd | Completed |
| 2 | Safety and Efficacy of HemocareLact Granules and HemocareLact Capsules on Breast Milk Production and Prolactin Levels in Postpartum Mothers | Rs. 5,40,200 | December 2018-December 2019 | MMC Pharmaceuticals. Ltd | Completed |
| 3 | Bioavailability and Tissue Distribution studies of Turmeric formulation | Rs. 2,10,000 | August 2019- January 2020 | Ethix Pharma | Completed |
| 4 | Safety and Efficacy of Fatty liver capsules | Rs. 1,53,000 | March 2020-Oct 20 | Aeon Formulations Private Limited | Completed |
| 5 | Safety and efficacy of LibidUp-PE on premature ejaculation: A randomized double-blind, placebo-controlled study | Rs.4,85,000 | February 2021-February 2022 | MMC Pharmaceuticals. Ltd | Completed |
| 6 | Toxicity studies of Herbex Cough syrup | Rs. 1,30,300 | June 2021- Aug 21 | Aravindh Herbals Private Limited | Completed |
| 7 | A Phase 1 Single Centre, randomized, double-blind, placebo controlled clinical pharmacokinetic drug interaction study between Simvastatin and PeaNoc XL in adult, healthy human volunteers | Rs.3,67,600 | July 2021-Ongoing | Apex Laboratories.Pvt.Ltd | Ongoing |
| 8 | Efficacy and Safety of Wellmune TM Capsules as an Add-on Therapy to Conventional Therapy in patients with Type 2 Diabetes Mellitus-A Randomized, Placebo Controlled, Double blind Trial | Rs.4,34,500 | October 2021- Ongoing | MMC Pharmaceuticals. Ltd | Ongoing |
| 9 | Respiratory diagnosis and monitoring tool for lung patho-physiology | Rs. 4,90,000 | January 2022- Ongoing | Newskye Innovations Private Limited | Completed |
| 10 | A Randomized controlled clinical study of Peanoc XL in reducing the joint inflammation in arthritis | Rs.4,57,380 | March 2022- Ongoing | Apex Laboratories Ltd | Completed |
| 11 | Safety and efficacy of BOOZLiv in patients with alcoholic liver diseases: A randomized, open-label trial. | Rs.5,05,000 | March 2022- Ongoing | MMC Pharmaceuticals. Ltd | Ongoing |
| 12 | Evaluation of Acute, Sub-Acute Toxicity and Efficacy of Apfil Tablets for Non Alcoholic Fatty Liver model in Rodents | Rs. 4,36,920 | September 2022- April 2023 | Apex Laboratories Private Limited | Completed |
| 13 | Cyanobacterial Toxicity assessment using biological and immunological Outside institute: techniques: A case study in “Veeranam lake” India | Rs. 22,000 | October 2022- December 2023 | Greensmed India | Completed |
| 14 | Efficacy and Safety of Cervispon Capsule in the management of Cervical Spondylosis: Spondylosis: A Randomized, Double-blind, Placebo, Controlled Trial | Rs.4,99,500 | October 2022- Ongoing | MMC Pharmaceuticals. Ltd | Ongoing |
| 15 | Effectiveness of BooZNilTM in the management of alcohol dependence: A randomized, double-blind, placebo-controlled trial | Rs.5,32,560 | October 2023- Ongoing | MMC Pharmaceuticals. Ltd | Ongoing |
| 16 | An open Labeled Prospective Clinical Study to evaluate the safety and Efficacy of Biozen Syrub | Rs. 9,00,750 | January 2024- Ongoing | Aathithya Herbal | Ongoing |
| 17 | Effect of EmbryoFixTM supplementation for improving fertility in women: A randomized, open-label trial | Rs. 5,47,200 | January 2024- Ongoing | MMC Pharmaceuticals. Ltd | Ongoing |
| 18 | Pre-Clinical screening of selected test formulation for its wound healing potential in diabetic model | Rs 22,000 | April 2024- Ongoing | Aaranya Biosciences Pvt Ltd. | Ongoing |
| 19 | Curative Effects of Bakuchiol Formulation on Imiquimod induced Psoriasis Model. | Rs. 5,19,600 | April 2024- Ongoing | Purple Lifesciences Pvt. Ltd | Ongoing |
| 20 | Toxicity and Efficacy screening of three test formulations using Imiquimod induced psoriasis model | Rs. 25,000 | April 2024- Ongoing | Aaranya Biosciences Pvt Ltd. | Ongoing |
| 21 | Qualitative And Quantitative Analysis of Multiple API from the Formulation by Comparing the Respective Standard Using HPLC | Rs. 15,600 | April 2024- Ongoing | Purple Lifesciences Pvt. Ltd | Ongoing |
| 22 | Effectiveness of BooZNilTM in the management of alcohol dependence: A randomized, double-blind, placebo-controlled trial | Rs.5,32,560 | Jul-24 | MMC Pharmaceuticals Pvt Ltd | Ongoing |
| 23 | Effect of UralbuTM on Microalbuminuria in Type 2 Diabetic Patients: A Randomized Controlled, double-blind Trial | Rs.5,69,600 | Dec-24 | MMC Pharmaceuticals Pvt Ltd | Ongoing |
| 24 | Efficacy and safety of Magnesium glycinate as an add on therapy in the management of selected inflammatory disorders | Rs.4,00,000 | Jan-25 | SYNPHARMA RESEARCH LABS | Ongoing |
| 25 | Genomic analysis of COPD and ILF in Indian Population | Rs. 3,60,000 | Feb-25 | Dr.Tiru’s Clinic’les Private Limited | Ongoing |
| 26 | Genetic association of inflammatory bowel disease in Indian Population | Rs.12,60,000 | Feb-25 | Dr.Tiru’s Clinic’les Private Limited | Ongoing |
| 27 | Genomic analysis of Heart failure in Indian Population | Rs.14,40,000 | Feb-25 | Dr.Tiru’s Clinic’les Private Limited | Ongoing |
| 28 | Safety And Anti Diabetic Efficacy For Formulation “DIA-B” | 2,87,520 | 2024 – Ongoing | Purple Lifesciences Pvt. Ltd | Ongoing |
| 29 | Antioxidant profiling of Puricyn 30 (Purple Corn anthocyanin) by various in vitro assays. | 45,180 | 2025 – Ongoing | Purple Lifesciences Pvt. Ltd | Ongoing |
| 30 | Assessing the Therapeutic Efficacy of Broncho Boost Capsules,in Allergic Asthma: A Preclinical Evaluation | 3,02,685 | 2025 – Ongoing | Purple Lifesciences Pvt. Ltd | Ongoing |
| 31 | A Randomized Controlled Trial to Evaluate the Efficacy of DiaB Max and Puricyn Based Interventions with and without Additional Ingredients or Allopathic Therapy in Managing Diabetes. | 7,05,222 | 2025 – Ongoing | Purple Lifesciences Pvt. Ltd | Ongoing |
| 32 | Pre-Clinical Screening Of Formulations For Anti Psoriatic Activity | 47,280 | 2025 – Ongoing | Purple Lifesciences Pvt. Ltd | Ongoing |
List Of Instruments And Infrastructure
| S.NO | EQUIPMENTS | TARIFF (Rs. ) |
| 1 | All Maze software analysis for Neurobehavioral Evaluation in Rodents | Rs. 1000/ study (Excluding Report writing) |
| 2 | Semi auto analyser (Biochemical Analysis) | Rs. 500/ Sample |
| 3 | Digital Plethysmometer | Rs. 100/ animal group |
| 4 | Hot and Cold Analgesiometer | Rs. 100/ animal group |
| 5 | T Maze (Rodents) | Rs. 100/ hour |
| 6 | Morris Water Maze (Rodents) | Rs. 100/ hour |
| 7 | Grip strength apparatus (Rodents) | Rs. 50/ animal group |
| 8 | Method development and Validation of pharmaceutical substances by using RP- HPLC. | |
| Single drug | Rs. 10000 | |
| Double drug | Rs. 15000 | |
| Triple drug | Rs. 18000 | |
| 9 | AQbD based Method development and Validation of pharmaceutical substances by using RP- HPLC. | |
| Single drug | Rs. 12000 | |
| Double drug | Rs. 17000 | |
| Triple drug | Rs. 20000 | |
| 10 | Method development and Validation of pharmaceutical substances by using HPTLC. | |
| Single drug | Rs. 7000 | |
| Double drug | Rs. 9000 | |
| Triple drug | Rs. 12000 | |
| 11 | AQbD based Method development and Validation of pharmaceutical substances by using RP- HPTLC. | |
| Single drug | Rs. 9000 | |
| Double drug | Rs. 11000 | |
| Triple drug | Rs. 13000 | |
| 12 | Method development and Validation of Biological substances by using RP- HPLC. | |
| Single drug | Rs. 20000 | |
| Double drug | Rs. 25000 | |
| Triple drug | Rs. 30000 | |
| 13 | AQbD based Method development and Validation of Biological substances by using RP- HPLC. | |
| Single drug | Rs. 22000 | |
| Double drug | Rs. 27000 | |
| Triple drug | Rs. 32000 | |
| 14 | Single injection (Pharmaceuticals / API) | Rs. 300 |
| 15 | RS-Method Development and Validation of single drug with 3-Impurities profile using HPLC | Rs. 25000 |
| 16 | RS-Method Development and Validation of double drug with 4-Impurities profile using HPLC | Rs. 35000 |
| 17 | Method development and Validation of pharmaceutical substances by using UV. | |
| Single drug | Rs. 3000 | |
| Double drug | Rs. 5000 | |
| 18 | Method development and Validation of Biological substances by using UV. | |
| Single drug | Rs. 6000 | |
| Double drug | Rs. 8000 | |
| 19 | AQbD Method development and Validation of pharmaceutical substances by using UV. | |
| Single drug | Rs. 5000 | |
| Double drug | Rs. 7000 | |
| 20 | Method development and Validation of Biological substances by using UV. | |
| Single drug | Rs. 5000 | |
| Double drug | Rs. 7000 | |
| 21 | Lyophiliser | Rs. 200/Sample |
| 22 | Brookfield Viscometer | Rs. 100/Sample |
| 23 | Homogeniser | Rs. 100/Hr |
| 24 | Sonicator (Ultra, Probe, Bath) | Rs. 100/Hr |
| 25 | Tablet Punching Machine | Rs. 1000/Hr |
